Table 2 Univariate treatment characteristics of adolescents
Characteristics | n | % | |
|---|---|---|---|
Years on ART (years) | 0–2 |   35 | 17.5 |
3–5 |   59 | 29.5 | |
More than 5 | 106 | 53.0 | |
CD4 count at initiation (cells/mL) | More than 500 |   54 | 27.0 |
200–499 |   45 | 22.5 | |
Less than 200 |   43 | 21.5 | |
Missing |   58 | 29.0 | |
Adherence status | Good > 95% | 160 | 80.0 |
Fair/poor < 95% |   40 | 20.0 | |
History of treatment failure | Yes |   29 | 14.5 |
No | 171 | 85.5 | |
WHO clinical stage | I | 143 | 86.1 |
II |      6 |   3.6 | |
III |   15 |   9.1 | |
IV |      2 |   1.2 | |
Nutritional status | Normal | 150 | 89.8 |
MAM |   13 |   7.8 | |
SAM |      4 |   2.4 | |
Regimen | AZT + 3TC + EFV |   76 | 38.0 |
AZT + 3TC + NVP | 116 | 58.0 | |
ABC + 3TC + EFV |      8 |   4.0 | |